Inhibition of thrombin generation by the zymogen factor VII: Implications for the treatment of hemophilia A by factor VIIa

Blood

Volumn 95, Issue 4, 2000, Pages 1330-1335

  Van 'T Veer, Cornelis ^a,b   Golden, Neal J ^a,c   Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; CONCENTRATION RESPONSE; DISEASE MODEL; DRUG MECHANISM; HEMOPHILIA A; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REACTION ANALYSIS;

EID: 0034651933     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1330.004k28_1330_1335     Document Type: Article

References (38)

1. Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Semin Hematol. 1992;29:213.
2. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991;30:10,363.
3. Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci. 1977;74:5260.
4. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood. 1992;80:25.
5. Hagen FS, Gray CL, O'Hara P, et al. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA. 1986;83:2412.
6. Radcliffe R, Nemerson Y. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem. 1975;250:388.
7. Lawson JH, Butenas S, Mann KG. The evaluation of complex-dependent interactions in human factor VIIa. J Biol Chem. 1992;267:4834.
8. Seligsohn U, Østerud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein and activated factor XII. J Clin Invest. 1979;64:1056.
9. Kisiel W, Fujikawa K, Davie EW. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). Biochemistry. 1977;16: 4189.
10. Wildgoose P, Kisiel W. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells. Blood. 1989;73:1888.
11. Butenas S, Mann KG. Kinetics of human factor VII activation. Biochemistry. 1996;35:1904.
12. Philippou H, Adami A, Amersey RA, Stubbs PJ, Lane DA. A novel specific immunoassay for plasma two-chain factor VIIa: investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes. Blood. 1997;89: 767.
13. Lawson JH, Butenas S, Ribarik N, Mann KG. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem. 1993; 268:767.
14. Hedner U, Glazer S, Pingel K, et al. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet. 1988;2 (8621):1193.
15. Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis Suppl. 1998;1:S147.
16. Zur M, Radcliffe RD, Obberdick J, Nemerson Y. The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen. J Biol Chem. 1982;257:5623.
17. Bajaj SP, Rapaport, SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem. 1981;11: 397.
18. van 't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III and heparin cofactor-II. J Biol Chem. 1997;272:4367.
19. van 't Veer C, Hackeng TM, Delahaye C, Sixma JJ, Bouma BN. Activated facter X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. Blood. 1994;84:1132.
20. Nesheim ME, Katzmann JA, Tracy PB, Mann KG. Factor V. Methods Enzymol. 1981;80:249.
21. Griffith MJ, Noyes CM, Church FC. Reactive site peptide structural similarity between heparin co-factor II and antithrombin III. J Biol Chem. 1985; 260:2218.
22. Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem. 1994;269:23,357.
23. Butenas S, van 't Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem. 1997;272:21,527.
24. Sorensen BB, Rao LV. Interaction of activated factor VII and active site inhibited activated factor VII with tissue factor. Blood Coagul Fibrinolysis. 1998;9 (Suppl 1):S67.
25. Bauer KA, Mannucci PM, Gringeri A, et al. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Blood. 1992;79:2039.
26. Rao LV, Bajaj SP, Rapaport SI. Activation of human factor VII during clotting in vitro. Blood. 1985;65:218.
27. Østerud B. How to measure Factor VII and factor VII activation. Haemostasis. 1983;13:161.
28. Van Deijk WA, van Dam-Mieras MC, Muller AD, Hemker HC. Evaluation of a clotting assay determining the activity state of factor VII in plasma. Haemostasis. 1983;13:192.
29. van 't Veer C, Golden NJ, Kalafatis M, Mann KG. Inhibitory mechanism of the protein C pathway on tissue factor induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor. J Biol Chem. 1997;272:7983.
30. Cawthern KM, van 't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood. 1998;91: 4581.
31. Hedner U. Dosing and monitoring NovoSeven treatment. Haemostasis. 1996;26(Suppl 1):102.
32. Mauser-Bunschoten EP, de Goede-Bolder A, Wielenga JJ, Levi M, Peerlinck K. Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium. Neth J Med. 198; 53:249.
33. Monroe DM, Hoffman M, Oliver JA, Roberts HR. A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis. 1998;9(Suppl 1):S15.
34. ten Cate H, Bauer KA, Levi M, et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest. 1993;92:1207.
35. Erhardtsen E, Ezban M, Madsen MT, et al. Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. Blood Coagul Fibrinolysis. 1995;6:388.
36. Repke D, Gemmell CH, Guha A, Turitto VT, Broze GJ Jr, Nemerson Y. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci USA. 1990;87:7623.
37. Mast AE, Broze GJ. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood. 1996;87:1845.
38. Marciniak E. Factor-Xa inactivation by antithrombin 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex. Br J Hematol. 1973;24:391.